Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Washington Trust Bancorp, Inc. (“Washington Trust” or the “Company”) (NASDAQ: WASH). Such...
-
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of JetBlue Airways Corporation (“JetBlue” or the “Company”) (NASDAQ: JBLU). Such investors are...
-
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Lucid Group, Inc. (“Lucid” or the “Company”) (NASDAQ: LCID). Such investors are advised to...
-
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Meridian Corporation (“Meridian” or the “Company”) (NASDAQ: MRBK). Such investors are...
-
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sanara MedTech, Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI). Such investors are...
-
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ducommun Incorporated (“Ducommun” or the “Company”) (NYSE: DCO). Such investors are...
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Erasca, Inc. (“Erasca” or the “Company”) (NASDAQ: ERAS). Such investors are advised to...
-
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Byrna Technologies Inc. (“Byrna Technologies” or the “Company”) (NASDAQ: BYRN). Such...
-
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Coty Inc. (“Coty” or the “Company”) (NYSE: COTY) and certain of its former...
-
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Grace Therapeutics, Inc. (“Grace” or the “Company”) (NASDAQ: GRCE). Such investors are...